Search research articles
Contact Us
Filters
Showing results (161-170 of 192) with videos related to
Page
of 20
Sort By:
Frontiers in Molecular Neuroscience
|
June 14, 2021
Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13
Ana Caroline Brambilla Falvella, Bradley Joseph Smith, Licia C Silva-Costa, et al.
Frontiers in Molecular Neuroscience
|
December 20, 2021
Corrigendum: Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13
Ana Caroline Brambilla Falvella, Bradley Joseph Smith, Licia C Silva-Costa, et al.
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)
|
January 10, 2014
Brazilian Medical Association guidelines for the diagnosis and differential diagnosis of panic disorder
Michelle Nigri Levitan, Marcos H Chagas, Ila M Linares, et al.
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)
|
March 26, 2015
Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report
Flávia de L Osório, Rafael F Sanches, Ligia R Macedo, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
March 18, 2011
Modulation of auditory and visual processing by delta-9-tetrahydrocannabinol and cannabidiol: an FMRI study
Toby T Winton-Brown, Paul Allen, Sagnik Bhattacharyya, et al.
Plos One
|
July 15, 2016
Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects
Aviva Breuer, Christeene G Haj, Manoela V Fogaça, et al.
Current Drug Targets
|
December 22, 2012
Clonazepam for the treatment of panic disorder
Antonio E Nardi, Sergio Machado, Leonardo Ferreira Almada, et al.
Plos One
|
August 26, 2016
Correction: Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects
Aviva Breuer, Christeene G Haj, Manoela V Fogaça, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
May 27, 2022
Cannabinoids modulate proliferation, differentiation, and migration signaling pathways in oligodendrocytes
Valéria de Almeida, Gabriela Seabra, Guilherme Reis-de-Oliveira, et al.
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)
|
June 2, 2021
Effect of two oral formulations of cannabidiol on responses to emotional stimuli in healthy human volunteers: pharmaceutical vehicle matters
José A Crippa, Luiz C Pereira Junior, Lívia C Pereira, et al.
Page
of 20
Search research articles
Search
Showing results (161-170 of 192) with videos related to
Sort By:
Page
of 20
Frontiers in Molecular Neuroscience
|
June 14, 2021
Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13
Ana Caroline Brambilla Falvella, Bradley Joseph Smith, Licia C Silva-Costa, et al.
Frontiers in Molecular Neuroscience
|
December 20, 2021
Corrigendum: Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13
Ana Caroline Brambilla Falvella, Bradley Joseph Smith, Licia C Silva-Costa, et al.
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)
|
January 10, 2014
Brazilian Medical Association guidelines for the diagnosis and differential diagnosis of panic disorder
Michelle Nigri Levitan, Marcos H Chagas, Ila M Linares, et al.
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)
|
March 26, 2015
Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report
Flávia de L Osório, Rafael F Sanches, Ligia R Macedo, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
|
March 18, 2011
Modulation of auditory and visual processing by delta-9-tetrahydrocannabinol and cannabidiol: an FMRI study
Toby T Winton-Brown, Paul Allen, Sagnik Bhattacharyya, et al.
Plos One
|
July 15, 2016
Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects
Aviva Breuer, Christeene G Haj, Manoela V Fogaça, et al.
Current Drug Targets
|
December 22, 2012
Clonazepam for the treatment of panic disorder
Antonio E Nardi, Sergio Machado, Leonardo Ferreira Almada, et al.
Plos One
|
August 26, 2016
Correction: Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects
Aviva Breuer, Christeene G Haj, Manoela V Fogaça, et al.
European Archives of Psychiatry and Clinical Neuroscience
|
May 27, 2022
Cannabinoids modulate proliferation, differentiation, and migration signaling pathways in oligodendrocytes
Valéria de Almeida, Gabriela Seabra, Guilherme Reis-de-Oliveira, et al.
Revista Brasileira De Psiquiatria (Sao Paulo, Brazil : 1999)
|
June 2, 2021
Effect of two oral formulations of cannabidiol on responses to emotional stimuli in healthy human volunteers: pharmaceutical vehicle matters
José A Crippa, Luiz C Pereira Junior, Lívia C Pereira, et al.
Page
of 20